GWS
NGM

Glassman Wealth Services’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Glassman Wealth Services’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-92
Closed -$98 – 2102
2023
Q3 		$98 Sell
92
-208
-69% -$430 ﹤0.01% 1969
2023
Q2 		$777 Sell
300
-144
-32% -$514 ﹤0.01% 1514
2023
Q1 		$1.81K Buy
+444
New +$2.05K ﹤0.01% 1277
2020
Q1 		– Sell
-15
Closed – – 1659
2019
Q4 		$0 Sell
15
-3
-17% -$44 ﹤0.01% 1554
2019
Q3 		$0 Buy
+18
New +$270 ﹤0.01% 1440

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glassman Wealth Services's NGM Position: Q4 2023 in Review

Glassman Wealth Services sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q4 2023, closing a stake of 92 shares — an estimated $98 sold.

Glassman Wealth Services first reported a position in NGM in Q3 2019 and held it in 5 quarters. The position peaked at $1.81K in Q1 2023. 83 funds tracked by Wall St. Rank hold NGM as of Q4 2023.

  • Glassman Wealth Services reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 92 NGM Biopharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $98.
  • Glassman Wealth Services first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • Glassman Wealth Services's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.81K in Q1 2023.
  • 83 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Glassman Wealth Services's 13F filing for Q4 2023, filed 12 Feb 2024.